메뉴 건너뛰기
International Clinical Psychopharmacology
Volumn 19, Issue 6, 2004, Pages 351-353
Aripiprazole and neuroleptic malignant syndrome
Author keywords

Aripiprazole; Atypical antipsychotics; Neuroleptic malignant syndrome
Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; LORAZEPAM;
EID: 8644292732     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200411000-00007     Document Type: Article
Times cited : (48)
References (14)
  • 1
    • 0037406258 scopus 로고    scopus 로고
    • Aripiprazole: A new atypical antipsychotic drug
    • Bowles TM, Levin GM (2003). Aripiprazole: a new atypical antipsychotic drug. Annal Pharmacother 37:687-694.
    • (2003) Annal Pharmacother , vol.37 , pp. 687-694
    • Bowles, T.M.1    Levin, G.M.2
  • 2
    • 0037321460 scopus 로고    scopus 로고
    • Aripiprazole: Efficacy and tolerability profile of a novel-acting atypical antipsychotic
    • Buckley PF (2003). Aripiprazole: efficacy and tolerability profile of a novel-acting atypical antipsychotic. Drugs Today 39:145-151.
    • (2003) Drugs Today , vol.39 , pp. 145-151
    • Buckley, P.F.1
  • 3
    • 23044517909 scopus 로고    scopus 로고
    • Atypical antipsychotics and neuroleptic malignant syndrome
    • Caroff SN, Mann SC, Campbell EC (2000). Atypical antipsychotics and neuroleptic malignant syndrome. Psychiatr Annal 30:314-321.
    • (2000) Psychiatr Annal , vol.30 , pp. 314-321
    • Caroff, S.N.1    Mann, S.C.2    Campbell, E.C.3
  • 4
    • 0030070128 scopus 로고    scopus 로고
    • Editortal: Neuroleptic malignant syndrome and catatonia: One entity or two?
    • Fink M (1996). Editortal: neuroleptic malignant syndrome and catatonia: one entity or two? Biol Psychiatry 39:1-4.
    • (1996) Biol Psychiatry , vol.39 , pp. 1-4
    • Fink, M.1
  • 5
    • 0035139702 scopus 로고    scopus 로고
    • Letter: Treating neuroleptic malignant syndrome as catatonia
    • Fink M (2001). Letter: treating neuroleptic malignant syndrome as catatonia. J Psychopharmacol 21:121-122.
    • (2001) J Psychopharmacol , vol.21 , pp. 121-122
    • Fink, M.1
  • 7
    • 10744232425 scopus 로고    scopus 로고
    • Mechanism of new antipsychotic medications: Occupancy is not just antagonism
    • Grunder G, Carlsson A, Wong DF (2003). Mechanism of new antipsychotic medications: occupancy is not just antagonism. Arch Gen Psychiatry 60:974-977.
    • (2003) Arch Gen Psychiatry , vol.60 , pp. 974-977
    • Grunder, G.1    Carlsson, A.2    Wong, D.F.3
  • 8
    • 0036335287 scopus 로고    scopus 로고
    • Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia?
    • Gurrera RJ (2002). Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia? Clin Neuropharmacol 25:183-193.
    • (2002) Clin Neuropharmacol , vol.25 , pp. 183-193
    • Gurrera, R.J.1
  • 9
    • 0029900832 scopus 로고    scopus 로고
    • Case study: Neuroleptic malignant syndrome without pyrexia
    • Hynes AF, Vickar EL (1996). Case study: neuroleptic malignant syndrome without pyrexia. J Am Acad Child Adolesc Psychiatry 35:959-962.
    • (1996) J Am Acad Child Adolesc Psychiatry , vol.35 , pp. 959-962
    • Hynes, A.F.1    Vickar, E.L.2
  • 10
    • 0036738786 scopus 로고    scopus 로고
    • Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder
    • Kane JM, Carson WH, Saha AR, McQuade RD, Ingenito GG, Zimb DL, Ali MW (2002). Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 63:763-771.
    • (2002) J Clin Psychiatry , vol.63 , pp. 763-771
    • Kane, J.M.1    Carson, W.H.2    Saha, A.R.3    McQuade, R.D.4    Ingenito, G.G.5    Zimb, D.L.6    Ali, M.W.7
  • 13
    • 0038488945 scopus 로고    scopus 로고
    • Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone versus placebo in patients with schizophrenia and schizoaffective disorder
    • Potkin SG, Saha AR, Kujawa MJ, Carson WH, Ali M, Stock E, et al. (2003). Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone versus placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 60:681-690.
    • (2003) Arch Gen Psychiatry , vol.60 , pp. 681-690
    • Potkin, S.G.1    Saha, A.R.2    Kujawa, M.J.3    Carson, W.H.4    Ali, M.5    Stock, E.6
  • 14
    • 0037263345 scopus 로고    scopus 로고
    • Aripiprazole: A review of its pharmacology and clinical use
    • Taylor DM (2003). Aripiprazole: a review of its pharmacology and clinical use. Int J Clin Pract 57:49-54.
    • (2003) Int J Clin Pract , vol.57 , pp. 49-54
    • Taylor, D.M.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.